Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia
Condition(s):Acute Myeloid Leukemia; IDH1 Gene Mutation; IDH2 Gene MutationLast Updated:May 13, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid Leukemia; IDH1 Gene Mutation; IDH2 Gene MutationLast Updated:May 13, 2020Unknown status
Condition(s):Acute Myeloid LeukemiaLast Updated:January 27, 2020Completed
Condition(s):GliomaLast Updated:November 7, 2018Completed
Condition(s):High Grade AstrocytomaLast Updated:February 28, 2024Not yet recruiting
Condition(s):GliomaLast Updated:May 13, 2016Unknown status
Condition(s):Cholangiocarcinoma With IDH1 Mutation; Solid Tumors With IDH1 MutationLast Updated:December 14, 2023Recruiting
Condition(s):IDH1 Mutation Myeloid NeoplasmsLast Updated:March 8, 2024Completed
Condition(s):Glioma, Malignant; Computer-AssistedLast Updated:August 8, 2023Active, not recruiting
Condition(s):Acute Myeloid Leukemia; Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Myelodysplastic SyndromeLast Updated:July 7, 2020Withdrawn
Condition(s):Recurrent IDH1/2 Mutated GliomaLast Updated:February 29, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.